Related Experiment Video
Updated: Jan 16, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Prognostic value of left atrial strain in significant aortic valve disease: a systematic review and meta-analysis
Na Chen1,2, Wenhui Gu1, Jun Wu1
1Department of Echocardiography, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Insights
Left atrial strain (PALS) is a valuable independent predictor of adverse cardiovascular events in patients with significant aortic valve disease. Lower PALS indicates a higher risk of adverse outcomes, highlighting its prognostic importance.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Medicine
Background:
- Aortic valve disease (AVD) research has historically focused on the left ventricle.
- Emerging evidence indicates left atrial strain (LAS) also holds prognostic significance in AVD.
Purpose of the Study:
- To systematically evaluate the prognostic value of left atrial strain in significant aortic valve disease.
- To assess the predictive capability of peak left atrial longitudinal strain (PALS) for adverse cardiovascular events.
Main Methods:
- A comprehensive systematic review and meta-analysis was conducted.
- Searched multiple databases for studies on aortic stenosis (AS) or aortic regurgitation (AR) using PALS.
- Primary endpoint included mortality, heart failure hospitalization, aortic valve replacement, pulmonary hypertension, and new-onset atrial fibrillation.
Main Results:
- 25 studies involving 7,195 patients were analyzed.
- Lower PALS was significantly associated with a higher incidence of primary endpoint events (SMD = -1.03, p < 0.05).
- Each unit increase in PALS reduced the risk of primary endpoint events by 7% (HR = 0.93, p < 0.001).
Conclusions:
- Peak left atrial longitudinal strain (PALS) is an independent predictor of adverse cardiovascular events in significant aortic valve disease.
- PALS demonstrates significant prognostic value for patients with aortic stenosis and aortic regurgitation.
Background:
Previous studies on aortic valve disease have mainly focused on the left ventricle, but increasing evidence suggests that left atrial strain also has prognostic value in significant aortic valve disease.
Objective:
To systematically evaluate the prognostic value of left atrial strain in significant aortic valve disease.
Methods:
Multiple electronic databases were searched for studies evaluating significant aortic stenosis (AS) or aortic regurgitation (AR) using peak left atrial longitudinal strain (PALS) from the inception of each database to 1 February 2025. There were no language or regional restrictions. The primary endpoint was a composite outcome comprising all-cause mortality, hospitalization for heart failure, aortic valve replacement, pulmonary hypertension, and postoperative new-onset atrial fibrillation.
Results:
A total of 25 studies were included, involving 7,195 patients, with 2,039 (28%) patients experiencing primary endpoint events. The PALS was lower in the positive group (EVENT+) compared to the negative group (EVENT-) (SMD = -1.03, 95% CI [-1.22, -0.84], p < 0.05). For each unit increase in PALS, the risk of the primary endpoint event decreased by 7% (HR = 0.93, 95% CI [0.91, 0.96], p < 0.001). PALS exhibited consistent incremental predictive value in both the AR and AS cohorts, although the strength of its effect and the underlying mechanisms varied between groups.
Conclusion:
PALS is an independent predictor of adverse cardiovascular events in patients with significant aortic valve disease. PALS has certain value in the prognosis of significant aortic valve disease.
Systematic Review Registration:
[www.crd.york.ac.uk/prospero/], identifier [CRD 42024623883].
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management

